Name: Retatrutide
Brand: RegenMed
SKU: RGN-RETA
Price: 1450 AED
Availability: InStock
Rating: 5.0 (4 reviews)

Question 1

What is Retatrutide?

Accepted Answer

Retatrutide (development code LY3437943) is a synthetic peptide described in the literature as a triple agonist, engaging the GIP, GLP-1 and glucagon receptors. It is supplied as a lyophilised powder for research and laboratory use only.

Question 2

What does 'triple agonist' mean?

Accepted Answer

It refers to activity at three receptors rather than one or two — in Retatrutide's case GIP, GLP-1 and glucagon. Published work treats the addition of glucagon-receptor agonism as the principal pharmacological distinction from dual GIP/GLP-1 agonists such as Tirzepatide. What that difference means functionally is the subject of ongoing published study.

Question 3

What purity has this batch been tested to?

Accepted Answer

The current batch was assayed by Janoshik Analytical at 99.67% by HPLC, and the full Certificate of Analysis is published on this page — it states the batch identifier and test date, so the figure traces to the material you receive.

Question 4

Is this compound third-party tested?

Accepted Answer

Yes. Every batch of Retatrutide is analysed by HPLC through an independent laboratory (Janoshik Analytical). Certificates of Analysis are published on the product page as each batch is verified — some are already up, others are still being processed. If you need the report for a specific batch before ordering, ask us and we will get it to you.

Question 5

What is a Certificate of Analysis, and why does it matter?

Accepted Answer

A Certificate of Analysis (COA) is an independent laboratory report confirming what a batch actually contains. For research work it matters because identity and purity are experimental variables: without batch-level analysis you cannot attribute a result to the compound rather than to an impurity. We publish COAs on the product page as batches are verified, and you can request the report for a specific batch at any time.

Question 6

How should Retatrutide be stored?

Accepted Answer

Retatrutide ships as supplied and should be held at −20 °C in the dark. Lyophilised peptides are generally more stable than material in solution, and published stability work consistently reports that repeated freeze–thaw cycles and prolonged light exposure are the main causes of degradation. Storage conditions should be recorded as part of any research protocol.

Question 7

Is this product intended for human use?

Accepted Answer

No. This material is supplied strictly for research and laboratory use only. It is not a medicine, it is not approved for human or veterinary use, and it is not intended to diagnose, treat, cure or prevent any disease. Purchasers are responsible for ensuring their intended use complies with all applicable laws and institutional requirements.

Question 8

How quickly is it shipped?

Accepted Answer

Orders are dispatched from our facility with tracked, discreet packaging and ship worldwide. International delivery typically completes within 3–5 working days once dispatched. You will receive tracking as soon as the order leaves us.

Retatrutide

Shipping & Returns

How It Works

What's Included

Safety & Storage

Key Features & Research Highlights

FAQ

Dosing Chart

Frequently Bought Together

Lab-tested purity, every batch.

Why it matters.

Triple-agonist peptide.

Verified by Janoshik.

Reference-grade.

Three receptors. One molecule.

GLP-1 receptor

GIP receptor

Glucagon receptor

Inside the vial.

Dosing & reconstitution calculator

Cited, not claimed.

Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial

Retatrutide for type 2 diabetes: a phase 2 trial

Retatrutide for metabolic dysfunction-associated steatotic liver disease

LY3437943: discovery to clinical proof of concept